Novo Nordisk A/S (NVO)

Last Closing Price: 128.05 (2024-03-27)

Cash Flow from Investing Activities (Quarterly)

Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.

Novo Nordisk A/S (NVO) had Cash Flow from Investing Activities of $-6.37B for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
$9.53B
$3.18B
$1.45B
$8.08B
$5.66B
$3.87B
$122.45M
$3.99B
$3.99B
$3.18B
$3.18B
$3.18B
$3.18B
$3.87B
$4.30B
4.48B
4.49B
$0.71
$0.71
Balance Sheet Financials
$20.28B
$13.21B
$25.39B
$45.66B
$24.63B
$2.98B
$5.56B
$30.19B
$15.47B
$6.70B
$15.47B
4.51B
Cash Flow Statement Financials
$15.81B
Cash Flow from Investing Activities
$-6.37B
$-9.17B
$1.84B
$2.09B
$252.50M
$312.03M
$-4.61B
--
Fundamental Metrics & Ratios
0.82
--
--
0.16
0.25
84.80%
40.63%
40.63%
--
41.92%
33.33%
$12.07B
--
--
--
0.21
0.31
0.87
103.24
20.52%
47.38%
6.95%
17.21%
$3.43
$2.68
$3.52